Park E, Park H, Cho H, Ma Y, Lee SY, Lee JW, et al. Clinical Significance of Random Urinary Vanillylmandelic Acid in Patients with Neuroblastoma. Clin Pediatr Hematol Oncol. 2018;25(2):142-8.

Lee JW, Son MH, Cho HW, Ma YE, Yoo KH, Sung KW, et al. Clinical significance of MYCN amplification in patients with high-risk neuroblastoma. Pediatric blood & cancer. 2018;65(10):e27257.

Cho HW, Lee JW, Ma Y, Yoo KH, Sung KW, Koo HH. Treatment Outcomes in Children and Adolescents with Relapsed or Progressed Solid Tumors: a 20-year, Single-Center Study. Journal of Korean medical science. 2018;33(41):e260.

Ma Y, Jang MA, Yoo HS, Ahn SY, Sung SI, Chang YS, et al. A Novel De Novo Pathogenic Variant in FOXF1 in a Newborn with Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins. Yonsei medical journal. 2017;58(3):672-5.

Lee JW, Lee S, Cho HW, Ma Y, Yoo KH, Sung KW, et al. Incorporation of high-dose (131)I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study. Journal of hematology & oncology. 2017;10(1):108.

Ma Y, Lee JW, Park SJ, Yi ES, Choi YB, Yoo KH, et al. Detection of MYCN Amplification in Serum DNA Using Conventional Polymerase Chain Reaction. Journal of Korean medical science. 2016;31(9):1392-6.